Jef Vizentin-Bugoni
Hawaii s Oahu island is one of the most disturbed ecosystems in the world. Non-native plants that stowed away on ships or were brought to the island by early settlers for lawns and gardens have now nearly wiped out native plants. If you go to most places in Hawaii, with the exception of some high elevation areas and Kauaʻi and the Big Island, you re going to stand in this forest and say, Look at that, this beautiful tropical forest, said Corey Tarwater, a University of Wyoming Assistant Professor in the department of zoology and physiology. The chances are, there s not one native plant around you. That it s all invasive plants that have been brought over for one reason or the other.
/PRNewswire/ Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that it has completed a focused analysis of the topline co-primary.
Coastal Carolina University — Grants Pre-Award Coordinator : The Journal of Blacks in Higher Education jbhe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jbhe.com Daily Mail and Mail on Sunday newspapers.
HistoSonics Receives Approval To Begin European #HOPE4LIVER Clinical Study
Company Now Cleared to Use Its Novel Sonic Beam Therapy in Dual U.S. and European Studies
News provided by
Share this article
Share this article
MINNEAPOLIS, Jan. 11, 2021 /PRNewswire/ HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today that it has received approval to initiate the company s second European clinical trial of its new platform technology, which is designed to use the science of histotripsy to mechanically destroy targeted liver tumors, from outside of the body. The study, similar to HistoSonics recent FDA approved #HOPE4LIVER U.S. Study, is a multi-center, open label, single arm trial to evaluate the safety and efficacy in destroying liver tumors and will build upon the company s first-in-man THERESA Study recently conducted in Barcelona, Spain. The company expects to begin enrolling patients in early 2021.